Cyient DLM Ltd

- No explicit mention of any current or future fundraising plans through debt or equity in the transcript. - The company has repaid external loans using IPO proceeds and currently has gross debt of around INR 250 crores, including internal debt from the parent. - Management indicated that the IPO proceeds have been mostly utilized as per plans, with no deviations. - Interest costs are expected to reduce in Q4 as existing loans are repaid. - The company is actively looking for acquisitions but has not closed any deals yet. - No specific plans disclosed for raising fresh funds through debt or equity at this time.

- A new facility has been identified in Mysore to support growth in the medical and industrial sectors; it is a leased premise in a software park being converted for this purpose, expected ready next financial year. - The anticipated capex on the Mysore plant is minimal, approximately a couple of million dollars. - A new precision machining facility was inaugurated in Bangalore, providing 36,000 sq ft of manufacturing capability, focusing on high-value, vertically integrated services. - Supply chain optimization is underway with a focus on automation, supported by new leadership hires to strengthen capabilities. - No significant additional SG&A or capital investments are currently expected beyond these plans, as stated by management. - Discussions indicate ongoing capacity utilization optimization, with Mysore near peak and Hyderabad with lower utilization but expected to support future growth.

- The company expects healthy growth in revenue supported by a robust and "sufficiently large" pipeline of orders. - Current order book visibility extends 12 to 18 months, with some orders executable over three years. - Management is confident about maintaining an order book around INR 2,000 crores for upcoming quarters. - The business is focused on converting a strong pipeline into orders, with a solid track record of doing so. - They anticipate growth not only from existing clients by increasing wallet share but also from new client additions. - Investments in leadership and capacity expansions (e.g., new facilities in Mysore and Bangalore) support growth in medical, industrial, aerospace, and defense sectors. - SG&A investments have peaked, with expectations to reach and sustain double-digit EBITDA margins as revenue grows. - Overall, positive outlook for FY25 growth with guidance to be provided in Q4 results.

- Revenue for Q3 FY24 grew by 49.7% YoY; nine-month revenue growth is 49.6%, indicating strong top-line momentum. - EBITDA margin for Q3 is 9.2%, slightly down due to planned SG&A investments aimed at scaling the business. - Management expects EBITDA margin to reach around 10%-10.5% in Q4 and inch further towards 11%-12% as scale benefits and mix improvement happen. - Profit after tax surged 222.6% YoY in Q3, boosted by other income and volume growth; nine-month profits doubled. - SG&A investments, including leadership additions and RSU costs, lead to near-term margin pressure but are positioned for medium-to-long-term growth towards $300-500 million revenue. - Order book remains strong and is sufficient for healthy growth in FY25 and beyond, supporting sustained revenue and profit growth. - Free cash flow expected to turn positive in Q4, enhancing financial health. - Overall, consistent growth trajectory with improving operating leverage expected over coming quarters.

- The current order book stands around INR2,294 crores, and it has been largely stable or slightly flat over recent quarters, with some lumpiness due to large strategic program timings. - The typical order execution period ranges roughly between 12 to 18 months, although some orders can extend up to 24-30 months depending on the industry. - Despite a flat order book trend recently, management expresses confidence in a healthy and considerable pipeline of orders which they expect to convert into business in the coming quarters, potentially leading to order book growth. - Recent disclosures indicate advanced discussions and potential deal closures, including several large deals and two new client additions in aerospace and defense sectors. - The company aims to maintain the current order book level (~INR2,000 crores+) with confidence, driven by consistent end market demand and an active pipeline. - Management plans to provide more detailed industry-wise order book breakup in future disclosures.